Laboratory findings in 40 patients with CCPD
| n/N (%) | |
|---|---|
| Blood | |
| High HbA1c level | 0/37 (0) |
| CRP level >1.0 mg/dL | 4/38 (10.5) |
| Hyperthyroidism | 1/37 (2.7) |
| Hypothyroidism | 3/37 (8.1) |
| Rheumatoid factor | 1/31 (3.2) |
| ANA ≥1:160 | 1/31 (3.2) |
| Anti-SS-A Ab | 0/35 (0) |
| Anti-SS-B Ab | 0/35 (0) |
| MPO-ANCA | 1/27 (3.7) |
| PR3-ANCA | 0/25 (0) |
| Anti-AQP4 Ab | 0/29 (0) |
| Antiganglioside Ab | 2/24 (8.3) |
| Antineurofascin155 Ab | 5/11 (45.5) |
| Monoclonal gammopathy | 1/28 (3.6) |
| CSF | |
| Amounts of protein >40 mg/dL | 33/40 (82.5) |
| Cell counts >5/µL | 11/40 (27.5) |
| Albuminocytological dissociation | 23/40 (57.5) |
| OB | 2/27 (7.4) |
| Increased IgG index level | 5/27 (18.5) |
Ab, antibodies; ANA, antinuclear antibody; AQP4, aquaporin 4; CCPD, combined central and peripheral demyelination; CRP, C reactive protein; CSF, cerebrospinal fluid; HbA1c, glycated haemoglobin; MPO-ANCA, myeloperoxidase-antineutrophil cytoplasmic antibody; N, number of cases collated; N, number of involved cases; OB, oligoclonal IgG bands; PR3-ANCA, proteinase-3-antineutrophil cytoplasmic antibody.